Structure, function, and regulation of neuronal Cdc2-like protein kinase

Area of Science:

• Neuroscience
• Molecular Biology
• Biochemistry

Background:

• Neurofilaments and tau proteins are key components of the neuronal cytoskeleton.
• Dysregulation of the neuronal cytoskeleton is implicated in neurodegenerative diseases, including Alzheimer's disease.
• Protein kinases play critical roles in regulating cellular processes through phosphorylation.

Purpose of the Study:

• To identify and characterize novel protein kinases involved in neurocytoskeleton regulation.
• To investigate the role of a newly discovered kinase in Alzheimer's pathology.
• To elucidate the structure and regulatory mechanisms of this novel neuronal kinase.

Main Methods:

• Protein purification from bovine brain.
• In vitro phosphorylation assays using neurofilament proteins (NF-H, NF-M) and tau proteins.
• Biochemical characterization of the purified kinase, including subunit analysis.
• Northern blot analysis for tissue distribution studies.

Main Results:

• A novel protein kinase was identified and purified from bovine brain.
• The kinase, termed neuronal cdc2-like kinase (cdk5), phosphorylates neurofilament proteins (NF-H, NF-M) and tau proteins.
• The active kinase is a heterodimer composed of a cdc2-like catalytic subunit (cdk5) and a 25 kDa regulatory subunit derived from p35.
• The regulatory subunit (p35) is essential for kinase activity and is predominantly expressed in the brain, conferring neuron-specificity.
• cdk5 exhibits phosphorylation site specificity similar to cdc2 kinase.

Conclusions:

• Neuronal cdc2-like kinase (cdk5) is a novel enzyme implicated in regulating neurocytoskeleton dynamics.
• The neuron-specific regulatory subunit p35 is crucial for cdk5 activity and localization.
• cdk5's phosphorylation targets suggest a potential role in Alzheimer's disease pathogenesis.
• Further research into cdk5 regulation may reveal insights into neurodegenerative processes.